MDS Virtual Congress 2020 Archives - Page 105 of 149

Phase I-II first-in-human clinical study of intraputamenal CDNF in Parkinson’s disease: Exploratory PET imaging endpoints of the 12-month treatment period

V. Kerstens, P. Fazio, J. Johansson, T. Granberg, S. Booms, H. Huttunen, M. Sjögren, M. Woolley, B. Murphy, P. Fielder, J. Baker, P. Skinner, M. Andreasson, G. Paul-Visse, R. Kivisaari, H. Bjartmarz, G. Lind, P. Almqvist, F. Scheperjans, H. Widner, P. Svenningsson, J. Rinne, A. Varrone (Stockholm, Sweden)
Phase I-II first-in-human clinical trial of intraputamenal CDNF in Parkinson’s disease: Exploratory fluid-based biomarker endpoints of the 12-month treatment period

H. Huttunen, S. Booms, H. Abdesselem, N. Majbour, O. El-Agnaf, I. Poggiolini, L. Parkkinen, A. Cryar, E. Sirka, J. Harris, M. Dove, M. Sjögren, M. Woolley, B. Murphy, P. Fielder, J. Baker, P. Skinner, M. Andreasson, G. Paul-Visse, R. Kivisaari, H. Bjartmarz, P. Almqvist, P. Almqvist, G. Lind, F. Scheperjans, H. Widner, P. Svenningsson (Espoo, Finland)
Phase I-II first-in-human clinical trial of intraputamenal CDNF in Parkinson’s disease: Topline results of the six-month double-blind placebo-controlled main study and the six-month active treatment extension study

S. Booms, H. Huttunen, J. Koskinen, M. Sjögren, M. Saarma, M. Woolley, B. Murphy, P. Fielder, J. Baker, P. Skinner, J. Rinne, A. Varrone, M. Andreasson, G. Paul-Visse, R. Kivisaari, H. Bjartmarz, G. Lind, P. Almqvist, F. Scheperjans, H. Widner, P. Svenningsson (Espoo, Finland)
Phenotype of Parkinson’s Disease in African Americans Using NIH Toolbox Motor Measures

M. Bailey, G. Stebbins, S. Anderson, D. Hall (Chicago, IL, USA)
Phenotypic analysis of subjects with homozygous and compound heterozygous PANK2 mutations in a single extended pedigree from the Dominican Republic (DR) PKAN cohort

F. Middleton, C. Muniz, I. Ojukwu, M. Santana Jimenez, P. Stoeter, R. Ericson, A. Espinoza, C. Bass, P. Roa, S. Baser (Santo Domingo, Dominican Republic)
Phenotypic heterogeneity in Chinese dystonia patients with KMT2B variants

X.Y Li, L. Wang, X.H Wan (Beijing, China)
Phenotyping spasticity-associated tonic spasms: implications for therapy

H. Abboud, S. Saad, M. Elkasaby, C. Kilbane (Cleveland, OH, USA)
Photophobia and Progressive Supranuclear Palsy

K. Hay, D. Mohanty, Y. Lin, H. Kang, J. Sellers-Gibson, D. Claassen (Nashville, TN, USA)
Physical Therapy and Deep Brain Stimulation in Parkinson Disease: A Pilot Randomized Controlled Trial

R. Duncan, K. Rawson, G. Earhart, L. Van Dillen, J. Perlmutter (Saint Louis, MO, USA)
Physical Therapy Role with Differential Diagonosis and Treatment with Dizziness and Multiple System Atrophy: A Case Study

J. Liu (Sacramento, CA, USA)